LTvax

N/A

Report date: 2025/01/26 18:31:14

Base Information

Drug NameLTvax

Drug Alias NameAPC-001 (APCure)Pseudomonas aeruginosa expressing large T antigen (APCure)

ClassificationBiologics > Antigen > Tumor antigenVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Therapeutic vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Merkel Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAPCure Sas

China Registration ClassN/A

Develop Information

Active CompaniesAPCure Sas

Inactive CompaniesN/A

Active IndicationsCarcinoma, Merkel Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A